Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000861446 | SCV001001758 | likely benign | DiGeorge syndrome | 2023-11-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001786419 | SCV002028834 | uncertain significance | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | Reported in a patient with congenital heart defect in published literature (PMID: 33995479); In-frame duplication of 4 amino acids in a non-repeat region; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33995479) |
Ambry Genetics | RCV002381909 | SCV002692336 | likely benign | Cardiovascular phenotype | 2021-09-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004742658 | SCV005354183 | likely benign | TBX1-related disorder | 2024-07-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |